BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8544842)

  • 21. Müllerian-inhibiting substance function during mammalian sexual development.
    Behringer RR; Finegold MJ; Cate RL
    Cell; 1994 Nov; 79(3):415-25. PubMed ID: 7954809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
    Hirobe S; He WW; Lee MM; Donahoe PK
    Endocrinology; 1992 Aug; 131(2):854-62. PubMed ID: 1639028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
    Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
    Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
    Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice.
    Wu X; Arumugam R; Baker SP; Lee MM
    Endocrinology; 2005 Feb; 146(2):589-95. PubMed ID: 15514087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gubernacular development in Müllerian inhibiting substance receptor-deficient mice.
    Bartlett JE; Lee SM; Mishina Y; Behringer RR; Yang N; Wolf J; Temelcos C; Hutson JM
    BJU Int; 2002 Jan; 89(1):113-8. PubMed ID: 11849175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
    Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
    J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.
    Meyers-Wallen VN; MacLaughlin D; Palmer V; Donahoe PK
    Mol Reprod Dev; 1994 Sep; 39(1):1-7. PubMed ID: 7999353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors.
    Petraglia F; Luisi S; Pautier P; Sabourin JC; Rey R; Lhomme C; Bidart JM
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1029-32. PubMed ID: 9506769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine and paracrine Müllerian inhibiting substance hormone signaling in reproduction.
    Ingraham HA; Hirokawa Y; Roberts LM; Mellon SH; McGee E; Nachtigal MW; Visser JA
    Recent Prog Horm Res; 2000; 55():53-67; discussion 67-8. PubMed ID: 11036933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An immunoassay to detect human müllerian inhibiting substance in males and females during normal development.
    Hudson PL; Dougas I; Donahoe PK; Cate RL; Epstein J; Pepinsky RB; MacLaughlin DT
    J Clin Endocrinol Metab; 1990 Jan; 70(1):16-22. PubMed ID: 2294129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mullerian inhibiting substance: a gonadal hormone with multiple functions.
    Lee MM; Donahoe PK
    Endocr Rev; 1993 Apr; 14(2):152-64. PubMed ID: 8325249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertoli cell-specific rescue of fertility, but not testicular pathology, in Dax1 (Ahch)-deficient male mice.
    Jeffs B; Ito M; Yu RN; Martinson FA; Wang ZJ; Doglio LT; Jameson JL
    Endocrinology; 2001 Jun; 142(6):2481-8. PubMed ID: 11356697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Müllerian inhibiting substance in reproduction and cancer.
    Donahoe PK
    Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
    Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
    Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibin--a non-steroidal regulator of pituitary follicle stimulating hormone.
    McLachlan RI; Robertson DM; de Kretser D; Burger HG
    Baillieres Clin Endocrinol Metab; 1987 Feb; 1(1):89-112. PubMed ID: 3109368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Inhibins, activins and anti-Müllerian hormone: structure, signalling pathways, roles and predictive value in reproductive medicine].
    Deffieux X; Antoine JM
    Gynecol Obstet Fertil; 2003 Nov; 31(11):900-11. PubMed ID: 14623553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
    Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
    Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.